PlainPharmaWatch

CMS Open Payments · Tool

Millicent US Inc vs Biocomposites Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Biocomposites Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 381, versus 4 for the other company. Its single largest recorded recipient represents 13.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Millicent US Inc
HHI 4 · top recipient 0.2%
Ranked #1,836 of 1,838 companies by HHI
Biocomposites Inc
HHI 381 · top recipient 13.4%
Ranked #1,389 of 1,838 companies by HHI

Payment Overview

Company A

Millicent US Inc

Total Payments
$137.2K
% of Industry
0.0%
Transactions
7,090
Avg per Transaction
$19.35
Recipients
7,090
Avg per Recipient
$19.35
Payment Types
2
Top Payment Type
Food and Beverage
Company B

Biocomposites Inc

Total Payments
$138.8K
% of Industry
0.0%
Transactions
1,315
Avg per Transaction
$105.57
Recipients
1,315
Avg per Recipient
$105.57
Payment Types
2
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

Millicent US Inc vs Biocomposites Inc - total reported payments in CMS Open Payments PY2024

Biocomposites Inc$138.8KMillicent US Inc$137.2K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Millicent US Inc

Food and Beverage $109.3K

79.7%

Education $27.9K

20.3%

Biocomposites Inc

Food and Beverage $74.1K

53.4%

Consulting Fee $64.7K

46.6%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Millicent US Inc

  1. 1

    CORAL SPICER

    $289.61 · 2 txns

  2. 2

    SHANNON MCAFEE

    $264.56 · 2 txns

  3. 3

    BROOKE MICHELE FAUGHT

    $255.28 · 7 txns

  4. 4

    VERONICA WOODFORD

    $239.59 · 15 txns

  5. 5

    CHRISTIAN CHOUCHANI

    $215.74 · 9 txns

Biocomposites Inc

  1. 1

    ILYA BENDICH

    $18,607.47 · 5 txns

  2. 2

    ROBERT JOSEPH WETZEL

    $13,000.00 · 10 txns

  3. 3

    STEPHEN QUINNAN

    $12,055.53 · 5 txns

  4. 4

    MATTHEW REGULSKI

    $4,113.92 · 4 txns

  5. 5

    TIMOTHY ALTON

    $3,600.00 · 1 txns

Summary Comparison

Metric Millicent US Inc Biocomposites Inc
Total Payments $137.2K $138.8K
% of Industry Total 0.0% 0.0%
Transaction Count 7,090 1,315
Avg per Transaction $19.35 $105.57
Recipient Count 7,090 1,315
Avg per Recipient $19.35 $105.57
Payment Type Count 2 2
Top Payment Type Food and Beverage Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.